SCHEMBL6448465

SCHEMBL6448465

CC(C)(C)NS(=O)(=O)c1ccc(Nc2nc(S(=O)(=O)COCc3ccccc3)nc3cc(-c4ncccc4C(F)(F)F)ccc23)cc1

nearest known ligand 0.62

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TRPV1 Q8NER1 20/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4973022 0.90 TRPV1 (0.76) TRPV1
SCHEMBL27600591 0.89 TRPV1 (0.62) TRPV1
SCHEMBL4977599 0.83 TRPV1 (0.76) TRPV1
SCHEMBL27600438 0.82 TRPV1 (0.60) TRPV1
SCHEMBL4973450 0.82 TRPV1 (0.80) TRPV1
SCHEMBL14307894 0.81 TRPV1 (0.79) TRPV1
SCHEMBL4972900 0.80 TRPV1 (0.80) TRPV1
SCHEMBL4975461 0.79 TRPV1 (0.72) TRPV1
SCHEMBL4908116 0.78 TRPV1 (0.89) TRPV1
SCHEMBL4917092 0.77 TRPV1 (1.00) TRPV1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1581225-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2005-10-05 EP disclosed
WO-2004054582-A1 COMBINATION THERAPY FOR THE TREATMENT OF PAIN NEUROGEN CORPORATION (US) 2004-07-01 WO disclosed